Tech Company Financing Transactions

RxREVU Funding Round

RxREVU, operating out of Denver, secured $4.7 million from private investors.

Transaction Overview

Company Name
Announced On
1/7/2017
Transaction Type
Venture Equity
Amount
$4,737,107
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 44 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
2601 Blake St. 450
Denver, CO 80205
USA
Email Address
Overview
RxREVU has over 6,000 cost-saving recommendations covering all of the major brand name chronic medications. The system uses twelve different cost-saving strategies to arrive at the most complete medication optimization solution available to healthcare portals and mobile applications today.
Profile
RxREVU LinkedIn Company Profile
Social Media
RxREVU Company Twitter Account
Company News
RxREVU News
Facebook
RxREVU on Facebook
YouTube
RxREVU on YouTube

Management Team

Title
Name
Email & Social
Chairman
Stephen McHale
  Stephen McHale LinkedIn Profile  Stephen McHale Twitter Account  Stephen McHale News  Stephen McHale on Facebook
Chief Executive Officer
Carm Huntress
  Carm Huntress LinkedIn Profile  Carm Huntress Twitter Account  Carm Huntress News  Carm Huntress on Facebook
Chief Financial Officer
Aaron Cornell
  Aaron Cornell LinkedIn Profile  Aaron Cornell Twitter Account  Aaron Cornell News  Aaron Cornell on Facebook
Chief Operating Officer
Christie Callahan
  Christie Callahan LinkedIn Profile  Christie Callahan Twitter Account  Christie Callahan News  Christie Callahan on Facebook
Chief Technical Officer
Gabe Hesse
  Gabe Hesse LinkedIn Profile  Gabe Hesse Twitter Account  Gabe Hesse News  Gabe Hesse on Facebook
President
Kyle Kiser
  Kyle Kiser LinkedIn Profile  Kyle Kiser Twitter Account  Kyle Kiser News  Kyle Kiser on Facebook
VP - Bus. Development
Benton Barney
  Benton Barney LinkedIn Profile  Benton Barney Twitter Account  Benton Barney News  Benton Barney on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/7/2017: Jupiter Orphan Therapeutics venture capital transaction
Next: 1/7/2017: Microbion venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to document tech company VC transactions. VC investment data records reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary